blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2616447

EP2616447 - PYRAZINE DERIVATIVES AS ENAC BLOCKERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.12.2015
Database last updated on 05.10.2024
Most recent event   Tooltip25.12.2015No opposition filed within time limitpublished on 27.01.2016  [2016/04]
Applicant(s)For all designated states
Novartis AG
Lichtstrasse 35
4056 Basel / CH
[2013/30]
Inventor(s)01 / BHALAY, Gurdip
Novartis Pharmaceuticals UK Limited
Wimblehurst Road
Horsham
West Sussex Sussex RH12 5AB / GB
02 / EDWARDS, Lee
Novartis Pharmaceuticals UK Limited
Wimblehurst Road
Horsham
West Sussex Sussex RH12 5AB / GB
03 / HOWSHAM, Catherine
Novartis Pharmaceuticals UK Limited
Wimblehurst Road
Horsham
West Sussex Sussex RH12 5AB / GB
04 / HUNT, Peter
Novartis Pharmaceuticals UK Limited
Wimblehurst Road
Horsham
West Sussex Sussex RH12 5AB / GB
05 / SMITH, Nichola
Novartis Pharmaceuticals UK Limited
Wimblehurst Road
Horsham
West Sussex Sussex RH12 5AB / GB
 [2013/30]
Representative(s)von Sprecher, Georg, et al
Novartis Pharma AG
Lichtstrasse 35
4056 Basel / CH
[N/P]
Former [2013/30]Mueller, Philippe
Novartis Pharma AG Patent Department
4002 Basel / CH
Application number, filing date11757864.116.09.2011
WO2011EP66151
Priority number, dateUS201161524495P17.08.2011         Original published format: US 201161524495 P
US20100383985P17.09.2010         Original published format: US 383985 P
[2013/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012035158
Date:22.03.2012
Language:EN
[2012/12]
Type: A1 Application with search report 
No.:EP2616447
Date:24.07.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 22.03.2012 takes the place of the publication of the European patent application.
[2013/30]
Type: B1 Patent specification 
No.:EP2616447
Date:18.02.2015
Language:EN
[2015/08]
Search report(s)International search report - published on:EP22.03.2012
ClassificationIPC:C07D241/26, C07D403/12, C07D487/10, A61K31/497, A61P11/00
[2013/30]
CPC:
C07D241/26 (EP,US); C07D471/10 (CN,KR); A61K31/4747 (KR);
A61P1/02 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P11/10 (EP); A61P11/12 (EP); A61P13/12 (EP);
A61P27/02 (EP); A61P27/04 (EP); A61P29/00 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P35/00 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P7/10 (EP);
A61P9/12 (EP); C07D403/12 (EP,KR,US); C07D487/10 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/30]
Extension statesBA17.04.2013
TitleGerman:PYRAZINDERIVATE ALS ENAC-BLOCKERS[2014/21]
English:PYRAZINE DERIVATIVES AS ENAC BLOCKERS[2013/30]
French:DÉRIVÉS DE PYRAZINE COMME BLOQUEURS DU CANAL SODIQUE ÉPITHÉLIAL[2014/21]
Former [2013/30]PYRAZINDERIVATE ALS ENAC-BLOCKER
Former [2013/30]DÉRIVÉS DE LA PYRAZINE EN TANT QUE BLOQUEURS DE L'ENAC
Entry into regional phase17.04.2013National basic fee paid 
17.04.2013Designation fee(s) paid 
17.04.2013Examination fee paid 
Examination procedure10.04.2013Amendment by applicant (claims and/or description)
17.04.2013Examination requested  [2013/30]
24.01.2014Despatch of a communication from the examining division (Time limit: M04)
09.04.2014Reply to a communication from the examining division
22.05.2014Communication of intention to grant the patent
30.07.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.09.2014Communication of intention to grant the patent
19.12.2014Fee for grant paid
19.12.2014Fee for publishing/printing paid
19.12.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.01.2014
Opposition(s)19.11.2015No opposition filed within time limit [2016/04]
Fees paidRenewal fee
12.09.2013Renewal fee patent year 03
12.09.2014Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[ID]WO2009074575  (NOVARTIS AG [CH], et al);
 [A]WO2009150137  (NOVARTIS AG [CH], et al);
by applicantUS3714357
 US3991761
 EP0039051
 EP0424021
 WO9219594
 US5171744
 JPH0525045B
 WO9318007
 WO9319749
 WO9319750
 WO9319751
 EP0642992
 WO9514089
 WO9720589
 WO9725086
 WO9730743
 WO9818796
 WO9916766
 WO9964035
 WO0000531
 WO0066558
 WO0066559
 WO0075114
 US6166037
 WO0104118
 WO0113953
 WO0142193
 WO0183462
 WO0200679
 WO0200652
 WO0210143
 WO0212266
 US2002055651
 WO0242298
 WO02051841
 WO02053564
 WO02066422
 WO02070490
 WO02076933
 WO02088167
 WO02100879
 WO03000840
 US6536427
 WO03024439
 WO03033495
 WO03035668
 WO03039544
 WO03042160
 WO03042164
 WO03048181
 WO03053966
 WO03062259
 WO03064445
 WO03072592
 WO03072539
 WO03077979
 WO03082280
 WO03082787
 WO03086294
 WO03087094
 WO03091204
 WO03099764
 WO03099807
 WO03101932
 WO03104195
 WO03104204
 WO03104205
 WO2004000814
 WO2004000839
 WO2004005229
 WO2004005258
 WO2004005285
 WO2004016601
 WO2004016578
 WO2004018425
 WO2004018429
 WO2004018450
 WO2004018451
 WO2004018457
 WO2004018465
 WO2004018431
 WO2004018449
 WO2004018422
 WO2004019935
 WO2004019944
 WO2004019945
 WO2004022547
 WO2004026873
 WO2004026248
 WO2004026841
 JP2004107299
 WO2004032921
 WO2004033412
 WO2004037805
 WO2004037768
 WO2004037773
 WO2004037807
 WO2004039827
 WO2004039762
 WO2004039766
 WO2004045607
 WO2004045618
 WO2004046083
 DE10261874
 EP1440966
 WO2004066920
 US2004167167
 WO2004074246
 WO2004074812
 WO2004078163
 WO2004080972
 WO2004080964
 WO2004108765
 WO2004108676
 WO2004111014
 WO2004110352
 WO2005026137
 WO2005035514
 WO2005037353
 US2005176761
 WO2005075435
 US2005183724
 WO2005113042
 WO2005120497
 WO2006099256
 WO2006101740
 WO2006127588
 WO2007021982
 WO2008051621
 WO2009074575
 WO2009117112
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.